ADVENZYMES302.20

Advanced Enzyme Tech Ltd.

· Pharma & Health
₹ CrorePeersAARTIPHARMAARTIDRUGSAGARWALEYEAKUMSALIVUSAPLLTDCORONAHCGMcap ₹3,382 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt25.121.520.520.5
Net Debt-491.5-552.9-672.1-672.1
Total Debt/Equity0.020.010.010.01
Net Debt/Equity-0.36-0.38-0.40-0.40
Total Debt/EBITDA0.120.110.090.09
Net Debt/EBITDA-2.40-2.84-2.93-3.01
Interest Coverage (EBIT/Interest)57.7944.3971.9171.91
Total Debt/Total Capital %1.801.451.201.20
As Filed — company-reported covenants
Debt/Equity (as filed)0.020.010.01
Debt Service Coverage (as filed)6.118.158.23
Interest Service Coverage (as filed)43.7771.0570.05
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.